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ABSTRACT  The incorporation  of iron  into  human cells  involves  the binding of diferric  transferrin to 
a specific  cell surface  receptor.  We studied the process  of endocytosis  in  K562,  a human erythroid 
cell  line,  by  using  tetramethylrhodamine  isothiocyanate-labeled  transferrin  (TRITC-transferrin)  and 
fluorescein  isothiocyanate-labeled  Fab  fragments  of goat  antireceptor  IgG  preparation  (FITC-Fab- 
antitransferrin receptor antibody). Because the antireceptor antibody and transferrin bind to different 
sites on the transferrin receptor molecule it was possible  to simultaneously and independently follow 
ligand  and  receptor.  At 4°C,  the  binding  of TRITC-transferrin  or  FITC-Fab  antitransferrin  receptor 
antibody  exhibited  diffuse  membrane  fluorescence.  At 20°C,  the  binding of TRITC-transferrin  was 
followed  by the  rapid  formation  of aggregates.  However,  the  FITC-Fab  antitransferrin  receptor did 
not show similar aggregation at 20°C  unless transferrin  was present.  In the  presence of transferrin, 
the  FITC-Fab  antitransferrin  receptor antibody  formed  aggregates  at the  same  sites and  within  the 
same time period as TRITC transferrin,  indicating co-migration. Although the diffuse surface  staining 
of either  label  was removed  by  proteolysis,  the  larger  aggregates  were not susceptible  to enzyme 
degradation,  indicating that they were intracellular.  The internal  location of the aggregates was also 
demonstrated  using  permeabilized  cells  that had  been preincubated  with transferrin and fixed with 
4%  paraformaldehyde.  These  cells  showed  aggregated  receptor  in  the  interior  of  the  cell  when 
reacted with fluorescein-labeled  antibody to the receptor. This indicated that the transferrin and the 
transferrin  receptor co-internalize and migrate to the same structures within the cell. 
Transferrin, an iron-binding serum protein, and its receptor 
on the plasma membrane are considered to be involved in a 
major pathway for the transport of iron  into cells.  Superfi- 
cially,  the  receptor appears to  act  as  a  cation  transporter; 
however, the detailed mechanism of the cellular internaliza- 
tion  of iron  is still  unclear.  Initial studies using  ~3q-labeled 
transferrin  and  cell  fractionation  found  transferfin  on  the 
surface of reticuiocytes (l). In more recent work, using ascites 
tumor cells,  ferrocyanide staining of transferrin and ferritin- 
conjugated antibody to transferrin also showed that transfer- 
fin is localized on  the  cell  surface (2).  In contrast,  there  is 
evidence that transferrin is pinocytosed into reticulocytes and 
normoblasts (3-5). In these studies, ferritin-conjugated anti- 
bodies to transferrin (3, 4) and transferrin-colloidal gold com- 
plexes  (5)  were  employed  to  visualize  the  localization  of 
transferrin. 
Experiments demonstrating that transferrin co-purifies with 
clathrin  in  human placental  tissues  (6,  7)  imply that  the 
mechanism of transferrin uptake into cells might be similar 
to  that  of many peptides,  i.e.,  asialoglycoprotein  receptor, 
yolk proteins, a-2 macroglobulin, and the hormones, insulin 
and epidermal growth factor (8, 9). Many studies of receptor- 
mediated endocytosis have been reported (10-15). In most of 
these  cases,  receptor internalization  has been  inferred,  and 
only ligand internalization  has been directly observed. Pro- 
tease digestion  of the  cell  surface or treatment with agents 
that destroyed ligand binding to its receptor was used in some 
of these  studies  to  suggest  that  ligand  internalization  was 
receptor mediated. 
Our study's purpose was to directly observe both the recep- 
tor and transferrin following the binding of the ligand to the 
receptor. In these studies, we fluorescently labeled transferrin 
and an antibody to the transferrin receptor to visually study 
them independently on the surface of K562 cells,  a  human 
erythroid cell line. 
MATERIALS  AND  METHODS 
Generation  of Fab Fragments from IgG:  Fab fragments  of an 
IgG  preparation of goat anti-human transferrin receptor in which all  cross- 
reactivity  with transferrin was eliminated (16) were prepared by digesting the 
antibody (6.8  mg/ml) with papain (0.12  mg/ml; Boehringer Mannheim Bio- 
chemicals, Indianapolis,  IN)  in  0.05  M  Tris-HCl,  2  mM  EDTA,  l  mM 
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© The Rockefeller University Press - 0021-9525/83/08/0579/07  $1.00  5  79 dithiothreitol,  pH 7.4, for 6 h at 37"C. The digested material was loaded onto 
a Protein A column (Pharmacia Fine Chemicals, Piscataway, N  J) equilibrated 
with 0.01 M Tris-HCI, pH 7.4, and the void volume collected. This material 
was judged  to  be  free of intact  heavy  chain  by SDS  14%  polyacrylamide 
electrophoresis under reducing conditions (17). 
Fluorochrome Labeling of fab Antitransferrin Receptor  and 
Transferrin:  The purified  Fab  fragment  of the antibody  to the  human 
transferrin receptor was labeled with fluorescein isothiocyanate (FITC) t (Sigma 
Chemical Co.; St. Louis, MO) in 1 M sodium bicarbonate,  pH 9.5, for 1 h at 
room temperature.  Unreacted FITC was removed by G-25 gel filtration (Pbar- 
macia Fine Chemicals) in phosphate-buffered saline (0.01 M sodium phosphate, 
0.15 M NaC1, pH 7.4 [PBS]). Iron-saturated  human transferrin (Sigma Chem- 
ical Co.) was labeled with 50 ~1 of  tetramethylrhodamine  isothiocyanate (2 mg/ 
ml dissolved in acetone) (Nordic Immunology, London) in 1 ml of I M sodium 
bicarbonate  at pH 9.5 for 3 h at room temperature.  Excess tetramethylrhoda- 
mine isothiocyanate (TRITC)  was removed by G25 (Pharmacia  Fine Chemi- 
cals) gel filtration in PBS. 
Incubation of Cells with Antibodies and Transferrin:  K562 
cells were washed twice with PBS and resuspended to 2 x  l& cells/ml in PBS 
with 1 mg/ml ovalbumin. FITC-labeled transferrin and/or TRITC-labeled Fab 
fragment of antitransferrin  receptor were added and incubated  at 4"C for 15 
min. The cells were then pelleted, washed, and resuspended to 1 x  107 cells/ml 
in PBS with  1 mg/ml ovalbumin.  Samples were stored on ice (15 min) until 
observed or photographed  under a fluorescence microscope. Samples (10 ~1) 
were dropped on slides, and a cover slip was placed over the sample. Ceils were 
either taken dimztly from the ice at 4"C and counted or photographed  within 
5 min, or else were allowed to warm to room temperature  either on the slide 
(5-10 min) or in the  incubation  tube (30 min) and then counted  or photo- 
graphed. 
Anti-human giycophorin generated  in goats was a gift of Dr. Leif C. An- 
dersson (18). FITC-labeled rabbit anti sheep IgG (Antibodies Inc., Davis, CA) 
was used as a second-step antibody  to visualize glycophorin  bound to cells. 
FITC-labeled  rabbit  anti  sheep  IgG did  not  show any  fluorescence  when 
incubated by itself with the ceils. 
Protease Digestion of Cell Surface Proteins:  Cells  (1  x  10  6 
cells/ml)  labeled with  fluorescent  probes  were prepared  as described  in the 
previous section, except that ovalbumin  was omitted  from the buffer in the 
final wash. Samples were warmed to room temperature and either immediately 
digested with Streptomyces greiseus protease (500/~g) (Sigma Chemical Co.) or 
allowed to incubate  for 15  or 30  min at room temperature  before protease 
digestion.  The  digestion  was carried  out  for 5  min at  room temperature. 
Ovalbumin  ( I mg) was added, the cells were cooled to 4"C, and washed with 
PBS containing  l  mg/ml ovalbumin.  Cell viability was 80-96%  judged  by 
trypan blue staining. 
Fixation of Cells:  Cells  (5 x  106) were washed free of growth media 
with PBS, resuspended with 0. l ml of the buffer, and fixed for 5 min at 4"C 
with  a  freshly  prepared  4%  paraformaldehyde  isotonic  phosphate-buffered 
solution according to the method of McDowell and Trump (19). After spinning 
at  1,000 g for 3 min, they were resuspended immediately  in RPMI  1640, 10 
mM sodium MOPS, pH 7.5, l mg/ml ovalbumin to stop further fixation. 
RESULTS 
Time Course and Temperature-dependence of 
the Internalization of Transferrin  and Its Receptor 
At  4"C,  the  binding  of either TRlTC-labeled transferrin 
(TRITC-transferrin) or the FITC-labeled Fab fragment of the 
antitransferrin  receptor antibody (FITC-Fab antitransferrin 
receptor antibody) exhibited diffuse membrane fluorescence. 
The  binding  was judged  to  be  specific because  unlabeled 
transferrin  added  in  100-fold  excess  simultaneously  with 
TRITC-transferrin could abolish the rhodamine fluorescence. 
Similarly, excess unlabeled antitransferrin receptor antibody 
added simultaneously with FITC-Fab antitransferrin receptor 
antibody could abolish the fluorescein fluorescence. Neither 
ovalbumin nor nonspecific goat IgG had any effect on the 
cellular fluorescence of FITC-Fab antitransferrin receptor an- 
tibody or TRITC-transferrin. When transferred to room tem- 
Abbreviations used in this paper: FITC, fluorescein isothiocyanate; 
and TRITC, tetramethylrhodamine isothiocyanate. 
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perature,  cells  incubated  with  TRITC-transferrin showed a 
transition  from diffuse membrane fluorescence to  brightly 
fluorescent patches (Fig.  1A). After 30 min at room temper- 
ature, the diffuse fluorescence diminished with coalescence of 
patches into aggregates (Fig.  1 C). By contrast, cells incubated 
with FITC-Fab antitransferrin  receptor antibody in the ab- 
sence of transferrin did not show the same pattern of fluores- 
cence. The fluorescence remained diffuse and showed essen- 
tially no patching at room temperature (Fig.  IB). Incubation 
simultaneously with both fluorescent labels showed co-migra- 
tion, co-patching, and co-coalescing of  TRITC-transferrin and 
FITC-Fab antitransferrin  receptor antibody (Figs.  1,  C  and 
D). Table I summarizes the percentage of the cells showing 
these transitions.  It was necessary to use a  monovalent Fab 
fragment of the antitransferrin receptor antibody to show this 
phenomenon. If purified whole IgG from the antiserum was 
labeled with FITC and incubated with cells,  then the same 
patterns of aggregation were seen with or without transferrin 
(Fig. 2, A, B, and C). 
Glycophorin Does Not Co-migrate with 
Transferrin  and Its Receptor 
We wanted to test whether the aggregation of the receptor/ 
transferrin  complex  is  restricted  to  these  two  proteins  or 
whether all the proteins on the surface of the K562 cells co- 
migrate. Cells incubated at room temperature in the presence 
of TRITC-transferrin and goat antiglycophorin (an antibody 
to a protein specific for the erythrocyte membrane) and FITC- 
labeled rabbit anti-goat IgG or all reagents together showed 
different membrane fluorescence patterns (Fig.  3, A and B). 
The TRITC-transferrin exhibited patches identical to those 
seen in Fig.  1. The fluorescence detected with goat antiglyco- 
phorin and FITC anti-goat IgG did not coaggregate with the 
transferrin and remained as diffuse stippled fluorescence. 
Susceptibility of TRITC-Transferrin and FITC-Fab 
Antitransferrin Receptor Antibody Binding to 
Protease  Treatment 
To determine whether the patched fluorescence represented 
internalized ligand and receptor, we tested the susceptibility 
of the fluorescence of each to proteolysis. When  cells were 
incubated for 15 min at 4"C with either TRITC transferrin or 
FITC-Fab antitransferrin  receptor antibody,  or both labels, 
then washed and digested for 5 min with protease, no fluores- 
cence could be detected. However, when cells were incubated 
at  room temperature for  15  min  so that  both  diffuse and 
patched fluorescence were present (Fig. 4, A and B), and then 
incubated for 5 min with protease, only the diffuse fluores- 
cence was susceptible to proteolytic attack. Thus, the patched 
fluorescence was unavailable to proteolysis (Fig. 4, C and D). 
Fluorescent Patterns  of Fixed Cells 
The results of the kinetic observations of the unfixed cells 
indicated that transferrin and the antibody to the transferrin 
receptor co-migrated to the cell interior, forming a fluorescent 
aggregate. Because neither of these probes, antibody or trans- 
ferrin,  is  covalently bound  to  the  receptor,  we  wanted  to 
determine whether the receptor was actually located in the 
same aggregates in which the transferrin migrates or whether 
the receptor was located elsewhere in the cell.  To examine 
this possibility, cells were preincubated with TRITC-transfer- FIGURE  1  Fluorescence microscope photographs of K562 cells showing specific binding of transferrin and antitransferrin receptor. 
(A) Cells were incubated with TRITC-transferrin  (2.5 x  10  -z M), washed, and incubated for 15 min at room temperature. (B) Cells 
were  incubated  with  FITC-Fab  fragments of goat anti-human transferrin  receptor, washed, and  incubated  for  15  min at  room 
temperature. (C and D) Cells were incubated with FITC-labeled Fab fragments of goat anti-human transferrin receptor and TRITC- 
transferrin  for 30  min at room temperature. The same field was photographed with a filter combination for rhodamine (C)  and 
fluorescein (D) fluorescence. In all cases the cells were initially washed free of culture media, resuspended at 1 x  106 cells/ml in 
phosphate  buffer  saline,  incubated  with  the  appropriate  fluorescent  label  or  labels  (5-10/A)  for  15  min  at  5°C,  pelleted  by 
centrifugation, and resuspended in PBS (107 cells/ml). Slides were made at room temperature and photographs were taken at the 
times listed in the figures. ×  400. 
TABLE  I 
Quantification of Changes  in Fluorescent Patterns on Cells with 
Time at Room Temperature 
Fab c~TR  Transferrin 
%  % 
Sample  %  diffuse  patched  %  diffuse  patched 
min 
0-2 
5-10 
30 
+  Fab c~TR*  90  -- 
+  Tff 
+  Both  s  72  7 
+  Fab  100  0 
+  Tf 
+  Both  6  91 
+  Fab c~TR  93  2 
+  Tf 
+  Both  4  83 
73  15 
62  10 
13  85 
6  91 
0  98 
4  83 
The total number of cells in each field were counted under phase-contrast 
optics. Each sample counted contained between 100 and 200 cells. 
* Fab aTR, FITC-labeled Fab fragment of goat anti-human transferrin receptor 
antibody. 
* Tf, TRITCqabeled diferric human transferrin. 
! Both, both fluorescent  reagents added simultaneously. 
fin, fixed with paraformaldehyde, and then incubated with 
the  FITC-labeled antibody to  the  receptor.  The  results are 
shown  in  Fig.  5.  Preincubation  of the  cells  with  TRITC- 
transferrin  at  room  temperature  for  15  min  followed  by 
fixation  (Fig.  5,  B  and  D)  shows  patterns  of diffuse  and 
patched fluorescence similar to those of unfixed cells incu- 
bated for comparable time periods at room temperature (Figs. 
1 C, 3A, and 4B). Addition of the FITC-labeled antireceptor 
antibody after fixation and permeabilization of  the cells shows 
that this antibody reacts at the same intracellular site in which 
the TRITC-transferrin is localized (Fig.  5). If the cells are not 
permeabilized,  then  the  antibody  does  not  have  access  to 
these aggregates (Fig.  5 C) and only very diffuse surface fluo- 
rescence  can  be  seen.  This  antibody  had  been  previously 
absorbed against transferrin to eliminate any crossreactivity 
with  transferrin  (16).  These  results  again  indicate  that  the 
aggregates or vesicles are located internally. 
DISCUSSION 
Using TRITC-transferrin, we studied the process oftransferrin 
binding and  internalization  in  K562  cells.  In addition,  the 
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transferrin  rabbit anti-goat IgG and  goat anti-human glycophorin, 
followed by FITC-mouse anti-goat IgG. (A and B) Cells were simul- 
taneously labeled with TRITC-transferrin and goat anti-human gly- 
cophorin, followed by FITC mouse anti-goat antisera. After washing 
and an additional incubation of 30 min at  room temperature the 
same field of cells  was photographed under rhodamine (A)  and 
fluorescein  (B) fluorescence,  x  400. 
FIGURE 2  Aggregation of transferrin  receptor with FITC-IgG anti- 
transferrin  receptor antibody. (A and B)  Fluorescence  patterns of 
cells incubated simultaneously with TRITC-transferrin and FITC-IgG 
antitransferrin  receptor antibody. Rhodamine fluorescence  is visu- 
alized in  A  and  fluorescein  fluorescence  is  visualized  in  B.  (C) 
Fluorescence pattern  of cells alone incubated with FITC-lgG anti- 
transferrin  receptor antibody.  In  all  experiments the  cells  were 
incubated for 15 min at room temperature, with fluorescent probes, 
pelleted, and resuspended to 107 cells/ml, after which slides were 
made. x  400. 
transferrin  receptor  has  been  independently  observed using 
an FITC Fab fragment of an anti-human transferrin receptor 
antibody generated in a goat. In a previous paper we demon- 
strated that transferrin does not compete with the binding of 
this antibody to the receptor (16). This enabled us to observe 
the  receptor  and  transferrin  independently  and  simultane- 
ously.  These  experiments  provide  direct  evidence  for  the 
internalization of transferrin in association with its receptor. 
van  Renswoude  et  al.  (20)  have  noted  that  transferrin  is 
internalized  in  K562  cells.  They used  fluorescently labeled 
transferrin  and  low  pH  washes  to  remove  surface-bound 
transferrin. We have shown that, in addition to the transferrin 
being internalized,  the  receptor co-internalizes in  the  same 
structure. 
A summary schematic of the events associated with trans- 
ferrin internalization is presented in Fig. 6. When transferrin 
was initially bound at 4°C it exhibited diffuse fluorescence at 
the  cell  surface,  and,  after  the  cells  were  brought  to  room 
temperature,  there were,  first,  clustering and, then,  aggrega- 
tion of the fluorescence. There was also a loss of susceptibility 
of the aggregated fluorescence to proteolytic digestion. This is 
presumably because the transferrin  has accumulated within 
intracellular aggregates. 
An interesting finding was the demonstration that the mon- 
ovalent Fab fragment of the antibody to human transferrin 
receptor did not internalize and migrate to the cell interior in 
the absence of transferrin. In the presence of transferrin it co- 
migrated to the cell interior forming a  fluorescent aggregate. 
Transferrin  may cause clustering and  internalization  of the 
582  RAPID  COMMUNICATIONS FIGURE  4  Fluorescence of cells  digested with  pronase. (A and  B) Cells were simultaneously incubated with  TRITC-transferrin 
and  FITC-Fab fragments of anti-human transferrin  receptor as described  in Fig.  1. The same field was photographed after a  15- 
min incubation at room temperature under rhodamine (A) and fluorescein (B) fluorescence. (C and D) Cells were simultaneously 
labeled  with  TRITC-labeled  transferrin  and  FITC-labeled  Fab  fragments  of  anti-human  transferrin  receptor.  After  a  15-min 
incubation at room temperature, cells were digested with Streptomyces griseus protease for 5 min as described in Materials and 
Methods. Ovalbumin was added, and the cells were spun down and resuspended in PBS and ovalbumin. The same field of cells 
is shown under rhodamine (C) and fluorescein (D} fluorescence, x  400. 
RAPID COMMUNICATIONS  583 FIGURE  5  Fluorescent patterns of cells fixed in 4% paraformaldehyde. Cells were preincubated for 15 min at room temperature 
with TRITC-transferrin (2 x  10  -7 M). They were then washed and fixed as described in Materials and Methods. This was followed 
by incubation with FtTC-antitransferrin receptor for 10 min at room temperature in PBS, 1 mg/ml ovalbumin, and 0.2% Triton X- 
100 to permeabilize the cells. The same field of cells is seen under fluoroscein fluorescence (A),  rhodamine fluorescence (B). The 
same experiment as described above was repeated but this time, after fixation, the cells were incubated with FITC-antitransferrin 
receptor antibody in the same buffer  lacking 0.2% Triton  X-100.  C  shows fluorescein fluorescence  due to  FITC-antitransferrin 
receptor antibody. D  shows rhodamine fluorescence due to TRITC-transferrin.  x  400. 
receptor by inducing a conformational change in the receptor 
molecule.  Alternatively,  transferrin binding may act to cross- 
link receptors close together,  as a necessary  step for internal- 
ization.  Perhaps,  the bifunctional nature of  the two ferric ion- 
binding sites of the transferrin polypeptide chains is related 
to this cross-linking  function. The experiments with the intact 
IgG preparation of the antibody to the receptor showed inter- 
nalization without transferrin being present.  However, this is 
still consistent with a requirement for cross-linking  of recep- 
tors by a binding agent since the IgG is bivalent. 
In addition to the time-course studies  showing co-migra- 
tion,  we  have shown with  fixed  cells  that the  receptor for 
transferrin can be found in the same intracellular  aggregate 
as  previously internalized  TRITC-transferrin.  The  internal 
location of the aggregate  was demonstrated by the need to 
have Triton X- 100 in the incubation buffer for the antirecep- 
tor antibody to gain access to this structure. This phenomenon 
was  specific  to transferrin  and  its  receptor because control 
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experiments using antibody to a different membrane antigen, 
glycophorin, did not show co-internalization. This observa- 
tion that transferrin does not cause the aggregation of  another 
major cell surface protein, glycophorin, is in agreement with 
the experiments of Ciehanover et al. (21), who demonstrated 
that the internalization and recycling of  the asialoglycoprotein 
receptor in a human hepatoma cell line is independent of the 
transferrin  receptor.  Thus  it  appears  to  be  a  very specific 
process. 
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FIGURE 6  Schematic representation of the results of the time course of the effects of antitransferrin receptor and transferrin 
binding on  K562 cells.  Transferrin was  labeled with  tetramethylrhodamine  isothiocyanate (TRITC-T}.  The  Fab fragment of the 
antibody was labeled with fluorescein isothiocyanate (FITC-Fab TR). In the last column, goat antibody to human glycophorin was 
visualized by  fluorescein isothiocyanate-labeled rabbit anti-goat IgG. TRITC fluorescence is denoted  by dashes (--)  and  FITC 
fluorescence is denoted by dots (.). 
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